The treatment is the comprehensive care surrounding it." GLP-1 medications are transforming obesity and cardio-kidney-metabolic carebut they should be prescribed within a comprehensive clinical model that includes: Thorough medical evaluation Personalized treatment planning Ongoing medication management Nutrition, behavioral, and lifestyle support Longitudinal follow-up to optimize outcomes Read the JAMA study: #ObesityMedicine #GLP1 #CardiometabolicHealth #Telehealth #DigitalHealth #eCKM #CKM #FlyteHealth To view or add a comment, sign in Great perspective from Katherine Saunders, MD, FTOS As GLP-1 access continues to grow, its important to remember that the medication is only one piece of the puzzle
Weaknesses: Limited to specific applications, potential for high development costs
Targeted GLP-1 Therapy for Unique Populations Women and Hormonal Balance Women face specific weight challenges, often linked to hormonal shifts, menopause, or conditions like PCOS
Cox, Lehninger Principles of Biochemistry, 7th Edition, W